Invention Grant
- Patent Title: Method for treating cancer using chemokine antagonists
-
Application No.: US15903503Application Date: 2018-02-23
-
Publication No.: US10660909B2Publication Date: 2020-05-26
- Inventor: John A. Zebala , Dean Y. Maeda , Aaron D. Schuler
- Applicant: Syntrix Biosystems Inc.
- Applicant Address: US WA Auburn
- Assignee: Syntrix Biosystems Inc.
- Current Assignee: Syntrix Biosystems Inc.
- Current Assignee Address: US WA Auburn
- Agency: Baker Hostetler
- Main IPC: A61K31/69
- IPC: A61K31/69 ; A61K33/24 ; A61P35/00 ; A61K39/395 ; A61K39/00 ; C07K16/28 ; A61K45/06
Abstract:
What is described is a method for treating cancer in a patient in need of such treatment through the use of an antagonist to CXCR1 and/or CXCR2 receptors by administering a therapeutically effective amount of an antagonist of CXCR1 and/or CXCR2, or pharmaceutical compositions thereof, either alone as monotherapy, or in combination with at least one other anticancer therapy.
Public/Granted literature
- US20180177808A1 METHOD FOR TREATING CANCER USING CHEMOKINE ANTAGONISTS Public/Granted day:2018-06-28
Information query
